Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Highlighting Welsh Cancer Research /
Towards blood based diagnostics in cancer

7th Sep 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 05.10.16
Views: 1297

Prof Dean Harris - Swansea University, Swansea, UK

Prof Harris speaks at the Highlighting Welsh Cancer Research Conference about the use of blood-based tumour markers, as reviewed by the Early Cancer Detection Consortium.

Highlighting circulating tumour cells (CTCs) and DNA methylation as assays currently available, he considers the shortfalls in specificity and clinical adoption of biomarkers, and introduces Grail as an upcoming assay aiming for better outcomes.

Prof Harris also discusses Raman spectroscopy, by which plasma may be assessed through laser scattering to determine the presence of CTCs.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation